Patents by Inventor Jianhao LI

Jianhao LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11950888
    Abstract: A pulse diagnostic device and a system of pulse diagnosis are provided. The pulse diagnostic device includes a cuff and a main monitor. The cuff includes a tube and an air bag arranged with an air path interface. A gas medium is received in the air bag. The tube is connected to the air path interface. The main monitor includes a pressure sensor and a controller. The tube extends to reach the main monitor and is connected to the pressure sensor, and the pressure sensor further connects to the controller. When the pulse diagnostic device is working, the cuff contacts an artery, the pressure sensor senses a pressure of the gas medium in the tube. The pressure sensor transmits the pressure of the gas medium to the controller. The controller obtains the pulse information and the blood pressure information based on the pressure of the gas medium.
    Type: Grant
    Filed: July 16, 2020
    Date of Patent: April 9, 2024
    Assignee: SHENZHEN TATFOOK WISDOM HEALTH TECHNOLOGY CO., LTD.
    Inventors: Yu Luo, Tiecai Li, Xianrui Liang, Tong Zhang, Jianhao Liu, Libao Zhang, Yating Li
  • Publication number: 20240025875
    Abstract: A compound serving as a thyroid hormone ? receptor agonist and uses of the compound, also provided is a pharmaceutical composition comprising the compound. The compound or the pharmaceutical composition is applicable in preparing a medicament for preventing, treating, or alleviating thyroid hormone ? receptor agonist-modulated diseases, and specifically applicable in preparing a medicament for treating nonalcoholic fatty liver disease.
    Type: Application
    Filed: September 16, 2021
    Publication date: January 25, 2024
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Jianchao DENG, Yongxiang LI, Haoxiong QIN, Daoqian CHEN, Xiaomin ZHENG, Jianghong YU, Huantian ZHAO
  • Patent number: 11795082
    Abstract: Disclosed is a split continuous operation micro-grid dynamic membrane bioreactor. The split continuous operation micro-grid dynamic membrane bioreactor comprises a biological treatment unit and a drum dynamic membrane filtration unit, wherein the biological treatment unit comprises a microbiological treatment tank, and a water inlet pipe is arranged on the microbiological treatment tank; the drum dynamic membrane filtration unit comprises a filter tank, and a drum micro-grid dynamic membrane mechanism is arranged in the filter tank; the drum micro-grid dynamic membrane mechanism comprises a filter drum, a backwashing device is arranged above the filter drum, and a sludge collecting tank is arranged in the filter drum; a water outlet is formed in the bottom of the filter tank; a mixed liquid pipe is arranged between the microbiological treatment tank and the filter drum; and a sludge discharge header pipe is arranged on the sludge collecting tank.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: October 24, 2023
    Inventors: Li Gu, Xiaofeng Xu, Jianhao Li, Wen Li, Meng Gao, Hua Xiang, Qiang He
  • Publication number: 20220411400
    Abstract: A chemical compound as a thyroid hormone Beta receptor agonist and a use thereof, further including a pharmaceutical composition containing the chemical compound. The chemical compound or pharmaceutical composition can be used in the preparation of drugs for preventing, treating or mitigation of diseases mediated by agonistic thyroid hormone ? receptor, particularly for the preparation of drugs for treating non-alcoholic fatty liver diseases.
    Type: Application
    Filed: September 23, 2020
    Publication date: December 29, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Xinshan DENG, Zheng LI, Daoqian CHEN, Jianchao DENG, Aizhen LV, Jianyu LIU
  • Publication number: 20220315536
    Abstract: An isoquinolinone compound acts as an inhibitor of semicarbazide-sensitive oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1), and the use thereof, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be used to prepare a drug for preventing, treating or ameliorating inflammation and/or inflammation-related diseases, diabetes and/or diabetes-related diseases in patients, and especially can be used to prepare a drug for preventing, treating or ameliorating non-alcoholic fatty liver diseases in patients.
    Type: Application
    Filed: May 20, 2020
    Publication date: October 6, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Weihua WANG, Haoxiong QIN, Xinshan DENG
  • Patent number: 11396495
    Abstract: An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: July 26, 2022
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Jianhao Li, Zheng Li, Weihua Wang, Haoxiong Qin, Xuli Wang, Jianyu Liu, Yingjun Zhang
  • Publication number: 20220055930
    Abstract: Disclosed is a split type continuous operation micro-grid dynamic membrane bioreactor. The split type continuous operation micro-grid dynamic membrane bioreactor comprises a biological treatment unit and a drum type dynamic membrane filtration unit, wherein the biological treatment unit comprises a microbiological treatment tank, and a water inlet pipe is arranged on the microbiological treatment tank; the drum type dynamic membrane filtration unit comprises a filter tank, and a drum micro-grid dynamic membrane mechanism is arranged in the filter tank; the drum micro-grid dynamic membrane mechanism comprises a filter drum, a backwashing device is arranged above the filter drum, and a sludge collecting bank is arranged in the filter drum; a water outlet is formed in the bottom of the filter tank; a mixed liquid pipe is arranged between the microbiological treatment tank and the filter drum; and a sludge discharge header pipe is arranged on the sludge collecting tank.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 24, 2022
    Inventors: Li GU, Xiaofeng XU, Jianhao LI, Wen LI, Meng GAO, Hua XIANG, Qiang HE
  • Publication number: 20200377461
    Abstract: An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 3, 2020
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Zheng LI, Weihua WANG, Haoxiong QIN, Xuli WANG, Jianyu LIU, Yingjun ZHANG